INTERDIGITATING DENDRITIC CELL SARCOMA
Clinical trials for INTERDIGITATING DENDRITIC CELL SARCOMA explained in plain language.
Never miss a new study
Get alerted when new INTERDIGITATING DENDRITIC CELL SARCOMA trials appear
Sign up with your email to follow new studies for INTERDIGITATING DENDRITIC CELL SARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Immunotherapy drug tested for rare blood cancers
Disease control TerminatedThis study tests the drug pembrolizumab in people with certain aggressive lymphomas or rare histiocyte/dendritic cell cancers that have come back or not responded to treatment. The goal is to see if the drug can shrink tumors. The study is currently suspended and enrolled 18 part…
Matched conditions: INTERDIGITATING DENDRITIC CELL SARCOMA
Phase: PHASE2 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
Scientists hunt for genetic clues in rare blood disorders
Knowledge-focused TerminatedThis study looks at the genetic makeup of rare blood diseases like Castleman disease and Langerhans cell histiocytosis. Researchers will analyze blood or tissue samples from 135 participants to find genetic changes that could be targeted by existing or experimental therapies. The…
Matched conditions: INTERDIGITATING DENDRITIC CELL SARCOMA
Phase: NA • Sponsor: Case Comprehensive Cancer Center • Aim: Knowledge-focused
Last updated Aug 08, 2026 00:03 UTC